Development
Covid-19 vaccine tracker, Sept 26: WHO makes financial case for investing in Covax facility
Vaccine headed to India enters phase-3 trials. A coronavirus vaccine being developed by US company Novavax has said it was beginning final stage …
To Read More, Please Visit Source
